Symeres announces acquisition of Oncolines

Austin Chemical is a long-standing representative of Symeres, a leading European drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). Symeres has recently announced the acquisition of Oncolines, a Netherlands-based CRO that provides early biology services and cell-line profiling assays. Please contact Austin Chemical for more information on Symeres and Oncolines’…

Happy Holidays

Austin Chemical will be closed on the following dates this holiday season: December 23rd, December 26th, December 30th and January 2nd, 2023. We wish all of our customers and partners seasons greetings and a happy new year!

Brominated Compounds

Austin Chemical has access to a novel sources of brominated compounds. Available reactor capacities are up to 45,000 L. Additional process capabilities include oxidation, grignard reactions and hydrogenations. Austin can source quality materials from bench to commercial scale. For more information and detailed specifications, please contact Austin Chemical. #quality #chemical #bromination

Austin Now Representing SIMS

Austin Chemical is proud to announce that we are a representative of SIMS (Società Italiana Medicinali Scandicci). SIMS is a CDMO specializing in hazardous reactions under cGMP, as well as low temperature reactions (-80C). They have a sound list of generic APIs and a long history of API life cycle management. Please reach out to…

Specialty Pharmaceutical Excipients

Austin Chemical is the North American distributor for Domino Sugar’s Specialty Pharmaceutical Excipients. We supply Di-Pac® Direct Compacting & Tableting Sugar, NF Granulated Sugars, and other sweeteners to the pharmaceutical industry. Di-Pac® is directly compressible, highly inert, and contains no invert sugar. Please contact Austin Chemical for more information on these products. #pharmaceutical #excipients